WolverHeme Happy Hour

A podcast by Bernard Marini, Anthony Perissinotti, et al.

31 Episodes

  1. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

    Published: 21/12/2022
  2. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

    Published: 14/12/2022
  3. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

    Published: 23/11/2022
  4. Episode (3+)7: Straight Outta Roswell - OG AML Data

    Published: 07/10/2022
  5. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

    Published: 21/07/2022
  6. Episode 5: IDH Inhibitors in AML: not so AGILE

    Published: 03/06/2022
  7. Episode 4: All Aboard the Oncology StewardSHIP

    Published: 27/05/2022
  8. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Published: 22/04/2022
  9. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Published: 22/04/2022
  10. Episode 2: We Don't Talk About Rylaze

    Published: 18/03/2022
  11. Episode 1: Surrogate Endpoints in AML

    Published: 11/03/2022

2 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Visit the podcast's native language site